Precision oncology company Prelude Therapeutics Inc. (PRLD) surged to a dramatic close on Monday, ending the regular trading session at $3.98, up $2.39 or 150.31%, marking one of its most significant single-day gains in recent memory. The spike pushed the stock near the upper end of its 52-week range of $0.61 to $4.19, fueled by a trading volume of over 29 million shares, a staggering increase compared to its average daily volume of just 243,363 shares.
However, the momentum cooled in after-hours trading, with the stock dipping to $3.33, a decline of $0.65 or 16.33% from the closing price. Despite the pullback, PRLD remains well above its recent lows and continues to attract attention amid upcoming clinical data and conference presentations.
For comments and feedback: editorial@rttnews.com